← FDA DRUG APPROVALS

FDA NDA · NDA012882

ISORDIL

Sponsor: WYETH AYERST

APPLICATION
NDA012882
TYPE
NDA
LATEST ACTION
1995-01-11
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE, TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

ISORDILDiscontinued
ISOSORBIDE DINITRATE 40MG · CAPSULE, EXTENDED RELEASE · ORAL
ISORDILDiscontinued
ISOSORBIDE DINITRATE 40MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

1995-01-11Labeling · Supplement 32 · standardAP
1991-10-16Manufacturing (CMC) · Supplement 34 · standardAP
1989-07-10Manufacturing (CMC) · Supplement 33 · standardAP
1989-06-16Manufacturing (CMC) · Supplement 25 · standardAP
1989-06-16Manufacturing (CMC) · Supplement 24 · standardAP
1988-07-29Labeling · Supplement 26 · standardAP
1980-12-12Manufacturing (CMC) · Supplement 15 · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →